A Director at Fluidigm Corp (NASDAQ: FLDM) is Buying SharesBy Carrie Williams
Following this transaction Samuel Colella’s holding in the company was increased by 20.37% to a total of $127.9K. In addition to Samuel Colella, 3 other FLDM executives reported Buy trades in the last month.
The company has a one year high of $11.05 and a one year low of $4.31. Currently, Fluidigm Corp has an average volume of 128.6K.
Starting in February 2016, FLDM received 19 Buy ratings in a row. Eight different firms, including Avondale and Cantor Fitzgerald, currently also have a Buy rating on the stock.
The insider sentiment on Fluidigm Corp has been positive according to 27 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Fluidigm Corp. develops, manufactures, and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.